# Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin

> **NCT02197078** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 189426 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02197078
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-30
- **Primary completion:** 2019-02-26
- **Final completion:** 2019-02-26
- **Target enrollment:** 189426 (ACTUAL)
- **Last updated:** 2020-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02197078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02197078, "Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02197078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*